454 related articles for article (PubMed ID: 37974196)
1. Iron and copper: critical executioners of ferroptosis, cuproptosis and other forms of cell death.
Li Y; Du Y; Zhou Y; Chen Q; Luo Z; Ren Y; Chen X; Chen G
Cell Commun Signal; 2023 Nov; 21(1):327. PubMed ID: 37974196
[TBL] [Abstract][Full Text] [Related]
2. From ferroptosis to cuproptosis, and calcicoptosis, to find more novel metals-mediated distinct form of regulated cell death.
Gu J; Guo C; Ruan J; Li K; Zhou Y; Gong X; Shi H
Apoptosis; 2024 Jun; 29(5-6):586-604. PubMed ID: 38324163
[TBL] [Abstract][Full Text] [Related]
3. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research.
Tong X; Tang R; Xiao M; Xu J; Wang W; Zhang B; Liu J; Yu X; Shi S
J Hematol Oncol; 2022 Dec; 15(1):174. PubMed ID: 36482419
[TBL] [Abstract][Full Text] [Related]
4. Ferroptosis and cuproptposis in kidney Diseases: dysfunction of cell metabolism.
Chen T; Liang L; Wang Y; Li X; Yang C
Apoptosis; 2024 Apr; 29(3-4):289-302. PubMed ID: 38095762
[TBL] [Abstract][Full Text] [Related]
5. Interplay of Ferroptosis and Cuproptosis in Cancer: Dissecting Metal-Driven Mechanisms for Therapeutic Potentials.
Wang J; Li J; Liu J; Chan KY; Lee HS; Lin KN; Wang CC; Lau TS
Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339263
[TBL] [Abstract][Full Text] [Related]
6. Revolutionizing breast cancer treatment: Harnessing the related mechanisms and drugs for regulated cell death (Review).
Ai L; Yi N; Qiu C; Huang W; Zhang K; Hou Q; Jia L; Li H; Liu L
Int J Oncol; 2024 May; 64(5):. PubMed ID: 38456493
[TBL] [Abstract][Full Text] [Related]
7. Regulated Cell Death in Endometriosis.
Huang E; Wang X; Chen L
Biomolecules; 2024 Jan; 14(2):. PubMed ID: 38397379
[TBL] [Abstract][Full Text] [Related]
8. The Cross-Communication of Cuproptosis and Regulated Cell Death in Human Pathophysiology.
Tsui KH; Hsiao JH; Lin LT; Tsang YL; Shao AN; Kuo CH; Chang R; Wen ZH; Li CJ
Int J Biol Sci; 2024; 20(1):218-230. PubMed ID: 38164173
[TBL] [Abstract][Full Text] [Related]
9. Crosstalk between ferroptosis and cuproptosis: From mechanism to potential clinical application.
Liu N; Chen M
Biomed Pharmacother; 2024 Feb; 171():116115. PubMed ID: 38181713
[TBL] [Abstract][Full Text] [Related]
10. Wilson Disease: Copper-Mediated Cuproptosis, Iron-Related Ferroptosis, and Clinical Highlights, with Comprehensive and Critical Analysis Update.
Teschke R; Eickhoff A
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731973
[TBL] [Abstract][Full Text] [Related]
11. Copper homeostasis and cuproptosis in mitochondria.
Tian Z; Jiang S; Zhou J; Zhang W
Life Sci; 2023 Dec; 334():122223. PubMed ID: 38084674
[TBL] [Abstract][Full Text] [Related]
12. Ferroptosis and cuproptosis: Metal-dependent cell death pathways activated in response to classical chemotherapy - Significance for cancer treatment?
Kciuk M; Gielecińska A; Kałuzińska-Kołat Ż; Yahya EB; Kontek R
Biochim Biophys Acta Rev Cancer; 2024 Jul; 1879(4):189124. PubMed ID: 38801962
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of Regulated Cell Death: Current Perspectives.
Santagostino SF; Assenmacher CA; Tarrant JC; Adedeji AO; Radaelli E
Vet Pathol; 2021 Jul; 58(4):596-623. PubMed ID: 34039100
[TBL] [Abstract][Full Text] [Related]
14. Inhibiting the compensatory elevation of xCT collaborates with disulfiram/copper-induced GSH consumption for cascade ferroptosis and cuproptosis.
Zhang P; Zhou C; Ren X; Jing Q; Gao Y; Yang C; Shen Y; Zhou Y; Hu W; Jin F; Xu H; Yu L; Liu Y; Tong X; Li Y; Wang Y; Du J
Redox Biol; 2024 Feb; 69():103007. PubMed ID: 38150993
[TBL] [Abstract][Full Text] [Related]
15. Ferroptosis inducers enhanced cuproptosis induced by copper ionophores in primary liver cancer.
Wang W; Lu K; Jiang X; Wei Q; Zhu L; Wang X; Jin H; Feng L
J Exp Clin Cancer Res; 2023 Jun; 42(1):142. PubMed ID: 37277863
[TBL] [Abstract][Full Text] [Related]
16. Elesclomol-copper synergizes with imidazole ketone erastin by promoting cuproptosis and ferroptosis in myelodysplastic syndromes.
Gao Y; Jin F; Zhang P; Zheng C; Zheng X; Xie J; Lu Y; Tong X; Du J; Zhang J; Wang Y
Biomed Pharmacother; 2024 Jun; 175():116727. PubMed ID: 38733771
[TBL] [Abstract][Full Text] [Related]
17. Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted therapies.
Liao M; Qin R; Huang W; Zhu HP; Peng F; Han B; Liu B
J Hematol Oncol; 2022 Apr; 15(1):44. PubMed ID: 35414025
[TBL] [Abstract][Full Text] [Related]
18. Cellular Trojan Horse initiates bimetallic Fe-Cu MOF-mediated synergistic cuproptosis and ferroptosis against malignancies.
Chen K; Zhou A; Zhou X; He J; Xu Y; Ning X
Sci Adv; 2024 Apr; 10(15):eadk3201. PubMed ID: 38598629
[TBL] [Abstract][Full Text] [Related]
19. Targeted regulated cell death with small molecule compounds in colorectal cancer: Current perspectives of targeted therapy and molecular mechanisms.
Li R; Wu Y; Li Y; Shuai W; Wang A; Zhu Y; Hu X; Xia Y; Ouyang L; Wang G
Eur J Med Chem; 2024 Feb; 265():116040. PubMed ID: 38142509
[TBL] [Abstract][Full Text] [Related]
20. The Role of Ferroptosis and Cuproptosis in Curcumin against Hepatocellular Carcinoma.
Liu Z; Ma H; Lai Z
Molecules; 2023 Feb; 28(4):. PubMed ID: 36838613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
